Drug intelligence / Profile preview

5G

Development stage
Unknown
Lead developer
Neurogenics Therapeutics
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
Administration
Oral
01

Overview

5G is an oral dietary supplement developed by Neurogenics Therapeutics, specifically formulated to support nerve health and address symptoms associated with peripheral neuropathy. The name 5G is derived from its five key active ingredients: methylcobalamin (Vitamin B12), benfotiamine (Vitamin B1), pyridoxal-5-phosphate (Vitamin B6), alpha-lipoic acid, and riboflavin (Vitamin B2). These components work synergistically to promote nerve regeneration, enhance myelin sheath integrity, and reduce oxidative stress. Methylcobalamin and benfotiamine provide highly bioavailable forms of essential vitamins that support nerve cell metabolism and structure, while alpha-lipoic acid acts as a potent antioxidant to mitigate nerve damage caused by free radicals. The product is marketed as a commercial solution for individuals seeking to manage neuropathic discomfort and maintain healthy neurological function.

Brand names
5G5G Nerve Support
Other names
Neurogenics 5GNeurogenics5GNeurogenics-5G5G Nerve Support Formula
02

Targets

DDC (Aromatic L-amino acid decarboxylase)MTR (Methionine synthase)TKT (Transketolase)GSR (Glutathione reductase)

Beyond the preview

Go deeper on 5G.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 5G.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call